跳至主要内容
临床试验/EUCTR2005-002216-25-IT
EUCTR2005-002216-25-IT进行中(未招募)不适用

A multicentre, randomised, open label, comparative Phase 4 trial to assess changes in clinical management after DaTSCAN imaging of subjects with clinically uncertain parkinsonism in a general neurologist setting - ND

GE Healthcare Ltd e le sue filiali0 个研究点目标入组 250 人开始时间: 2006年8月30日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
250

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Subjects with clinically uncertain Parkinsonian Syndromes PS or monosymptomatic, atypical or incomplete presentation of tremor, rigidity, bradykinesia or postural instability. Onset of clinical manifestations within the last 5 years.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Differential diagnosis between Parkinson s Disease PD and Progressive Supranuclear Palsy PSP or between PD and Multiple System Atrophy MSA . Subjects with an established/certain movement disorder clinical diagnosis. Presence of known causes of tremor eg. Hyperthyroidism . Subjects with a significant cognitive impairment as confirmed by a Mini-Mental State Examination score 24.

研究者

发起方
GE Healthcare Ltd e le sue filiali

相似试验